USA Manufacturers Directory

Replimune, INC.

Oncolytic immunotherapies for cancer treatment

Replimune develops oncolytic immunotherapies for cancer patients, with treatments intended to stimulate tumor-specific immune responses. Its FDA-approved therapy, TUDRIQEV, is used with nivolumab for advanced melanoma following progression on an anti-PD-1-containing regimen. The company also evaluates investigational therapies for solid tumors in clinical trials.

At a Glance

Replimune, INC. is an American manufacturer based in Woburn, MA.

Where
Woburn, MA

Categories